Titre:
  • An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
Auteur:Schöffski, Patrick; Adkins, Douglas; Blay, Jean Yves; Gil, Thierry; Elias, Anthony A.D.; Rutkowski, Piotr; Pennock, Gregory G.K.; Youssoufian, Hagop; Gelderblom, Hans; Willey, R.; Grebennik, Dmitri D.O.
Informations sur la publication:European journal of cancer, 49, 15, page (3219-3228)
Statut de publication:Publié, 2013-10
Sujet CREF:Cancérologie
Mots-clés:Adipocytic sarcoma
Cixutumumab
Ewing family of tumours
Insulin-like growth factor receptor
Leiomyosarcoma
Rhabdomyosarcoma
Soft-tissue sarcoma
Synovial sarcoma
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2013.06.010
info:pii/S0959804913004851
info:scp/84884910107
info:pmid/23835252